Submissions from 2021
Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial, John Paul Diaz, Troy Gatcliffe, Zuanel Diaz, Eric Schroeder, Nicholas Lambrou, Nicole Eiseler, and Thomas Morrissey
Immunotherapy in combination with PARP inhibition in advanced cervical cancer patients functionally competent or deficient for the Fanconi anemia repair pathway, John Paul Diaz, Nicholas Lambrou, Troy Gatcliffe, and Thomas Morrissey
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study, John Paul Diaz and Eric Schroeder
Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial, Nicholas Lambrou and John Paul Diaz
Submissions from 2020
Systemic Therapy for Gynecologic Malignancies, John Paul Diaz
Fertility Preservation in the Setting of Breast and Gynecologic Cancers and Cancer Treatment, John Paul Diaz and Elina Melik-Levine
Submissions from 2018
Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?, John Paul Diaz
Submissions from 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper, John Paul Diaz and Jeffrey Boyd